Jyong Biotech Ltd. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Jyong Biotech Ltd. (MENS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.07% for the 12-month period ending 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-05-15
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2024-12-31 | -0.07% 20-F · filed 2026-05-15 |
| 2023-12-31 | -0.09% 20-F · filed 2026-05-15 |